Ph1 Marinol Interaction Study - Part 2 - 1

Completed · Phase 1 · Has a placebo group

Conditions studied: Marijuana Dependence

In brief

This study will examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (PK), and cardiovascular effects of the combination of oral dronabinol and smoked marijuana to determine if there are potential significant drug interactions before conducting outpatient studies.

Key facts

Study ID

NCT00490269

Run by

National Institute on Drug Abuse (NIDA)

People needed

12

Starts

2006-10-01

Expected to finish

2007-12-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must be between 18 and 45 years of age
• Must be in good general health and who meet DSM-IV diagnostic criteria for marijuana dependence
• Must be seeking treatment at time of study entry
• Must be able to understand and provide written informed consent
• Must provide 1 marijuana positive urine specimen (> 50 ng/mL) within the 28-day screening period
• If female and of child bearing potential, agrees to use birth control.

You may not qualify if…

• Please contact site for more information

Where it is running

• Uniformed Services University of Health Science — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.